Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Achieving market access and reimbursement for psychedelic therapy

PS2023-294-tn

Achieving market access and reimbursement for psychedelic therapy

In order for psychedelic therapy to become widely accessible, it will be essential for the drugs and treatments be covered by insurance providers. In this panel, we will hear from experts about what payors will require in order to support psychedelic therapy.

Share: Achieving market access and reimbursement for psychedelic therapy

Facebook
Twitter
LinkedIn
Email

Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.

Report an Error

The PS2023: The Virtual Trip team has worked hard to create session captions, transcripts, and web pages as accurately as possible, but we know that some errors may have made it past our review process. Let us know what needs to be fixed! Please provide the session name and/or page URL where you found the error, the time the error occurs (if in a video), and the correct information we should use to fix the error. We appreciate your help in making PS2023: The Virtual Trip even better!

Name
Hidden
This field is for validation purposes and should be left unchanged.